"Unsere Klinik ist ein Referenzzentrum mit weltweiter Reputation für die Abklärung, Behandlung und Prävention von Krankheiten der Haut, der Nägel und der Haare. Als akademisches Zentrum arbeiten wir intensiv an Verbesserungen bei Diagnose und Behandlung unter kontrollierten Bedingungen (klinischen Studien)."

During the past decade, University Hospital Zurich, Department of Dermatology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Zurich, Department of Dermatology" #1 sponsor was "University of Zurich" with 7 trials, followed by "CatalYm GmbH" with 1 trials sponsored, "Cytos Biotechnology AG" with 1 trials sponsored, "Günther Hofbauer" with 1 trials sponsored and "Seagen Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Zurich, Department of Dermatology" #1 collaborator was "AlleCure" with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator and "University of Zurich" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Zurich, Department of Dermatology" are "Allergic Asthma" (1 trials), "Basal Cell Carcinoma" (1 trials), "Carcinoma, Squamous Cell" (1 trials), "Cutaneous Lymphoma" (1 trials) and "Disease, Hodgkin" (1 trials). Many other conditions were trialed in "University Hospital Zurich, Department of Dermatology" in a lesser frequency.

Most popular intervention types in "University Hospital Zurich, Department of Dermatology" are "Drug" (6 trials), "Biological" (3 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Allergen specific immunotherapy" (1 trials), "Apremilast 30mg" (1 trials), "CTL-002" (1 trials), "CYT005-AllQbG10" (1 trials) and "Canakinumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Zurich, Department of Dermatology" are 11 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Zurich, Department of Dermatology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University Hospital Zurich, Department of Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Zurich, Department of Dermatology, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".